{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:44:49Z","timestamp":1793108689178,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000875","name":"The Pew Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["25-18189L"],"award-info":[{"award-number":["25-18189L"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030_232029"],"award-info":[{"award-number":["320030_232029"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030L_231465"],"award-info":[{"award-number":["320030L_231465"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_215559"],"award-info":[{"award-number":["310030_215559"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030E_205323"],"award-info":[{"award-number":["310030E_205323"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["IZSEZ0_217585"],"award-info":[{"award-number":["IZSEZ0_217585"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"US Department of Energy Basic Energy Sciences","doi-asserted-by":"publisher","award":["DE-AC02-76SF00515"],"award-info":[{"award-number":["DE-AC02-76SF00515"]}],"id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI111825"],"award-info":[{"award-number":["U19 AI111825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI138938"],"award-info":[{"award-number":["P01 AI138938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI124690"],"award-info":[{"award-number":["R01 AI124690"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI137276"],"award-info":[{"award-number":["R01AI137276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI151698"],"award-info":[{"award-number":["U01 AI151698"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001447","name":"Rita Allen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013905","name":"Swiss Vaccine Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006206","name":"Biological and Environmental Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000010","name":"The Ford Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["871029"],"award-info":[{"award-number":["871029"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101191725"],"award-info":[{"award-number":["101191725"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["AV21-Virology"],"award-info":[{"award-number":["AV21-Virology"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/23_021\/0012621"],"award-info":[{"award-number":["CZ.02.01.01\/00\/23_021\/0012621"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM133894"],"award-info":[{"award-number":["P30GM133894"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.immuni.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:43:28Z","timestamp":1782139408000},"page":"2015-2029.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of West Nile disease convalescents identifies human monoclonal antibodies protective against West Nile and related orthoflaviviruses"],"prefix":"10.1016","volume":"59","author":[{"given":"Tom\u00e1s","family":"Cervantes Rinc\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Frckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaria I.","family":"Contejean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Cantergiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Cena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone G.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jarrossay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tosolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Kuratli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Cizkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Niejadlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Kr\u00e1tka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Mijatovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Gruji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Holoubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorana","family":"Budakov-Obradovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Salat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"H\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Vrane\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvezdana","family":"Lojpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajana","family":"Lendak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini\u0161a","family":"Sevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Baj\u010di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Popovi\u0107-Dragonji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Popovska Jovi\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagoda","family":"Gavrilovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Bournazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Palus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavle","family":"Banovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ruzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher O.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-3484","authenticated-orcid":false,"given":"Davide F.","family":"Robbiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2026.05.013_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2026.05.013_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/v15040860","article-title":"A Perspective on Current Flavivirus Vaccine Development: A Brief Review","volume":"15","author":"Dutta","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.immuni.2026.05.013_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2026.05.013_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5501\/wjv.v1.i2.51","article-title":"West Nile virus: A re-emerging pathogen revisited","volume":"1","author":"Mart\u00edn-Acebes","year":"2012","journal-title":"World J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1474-4422(07)70030-3","article-title":"West Nile virus","volume":"6","author":"Kramer","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.immuni.2026.05.013_bib6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1017\/S0950268806006339","article-title":"Risk factors for encephalitis and death from West Nile virus infection","volume":"134","author":"Murray","year":"2006","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.immuni.2026.05.013_bib7","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients","volume":"348","author":"Iwamoto","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230661","article-title":"Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in \u223c40% of patients","volume":"220","author":"Gervais","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.it.2006.05.007","article-title":"CCR5: no longer a \u201cgood for nothing\u201d gene--chemokine control of West Nile virus infection","volume":"27","author":"Lim","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2026.05.013_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/524691","article-title":"Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic","volume":"197","author":"Lim","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.immuni.2026.05.013_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/cei.12863","article-title":"Age-related alterations in immune responses to West Nile virus infection","volume":"187","author":"Montgomery","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.immuni.2026.05.013_bib12","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250189","article-title":"Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts","volume":"2","author":"Gervais","year":"2026","journal-title":"J. Hum. Immun."},{"key":"10.1016\/j.immuni.2026.05.013_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240637","article-title":"Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in \u223c10% of patients","volume":"221","author":"Gervais","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib15","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240942","article-title":"Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease","volume":"221","author":"Gervais","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41600-3","article-title":"Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.013_bib17","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.36.2200653","article-title":"Rapid increase in neuroinvasive West Nile virus infections in humans, Italy, July 2022","volume":"27","author":"Riccardo","year":"2022","journal-title":"Euro Surveill."},{"key":"10.1016\/j.immuni.2026.05.013_bib18","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/v5123021","article-title":"Vector-virus interactions and transmission dynamics of West Nile virus","volume":"5","author":"Ciota","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.immuni.2026.05.013_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2023.100664","article-title":"Genomic epidemiology of West Nile virus in Europe","volume":"18","author":"Koch","year":"2024","journal-title":"One Health"},{"key":"10.1016\/j.immuni.2026.05.013_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008042","article-title":"Twenty years of West Nile virus spread and evolution in the Americas visualized by Nextstrain","volume":"15","author":"Hadfield","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2026.05.013_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2023.100509","article-title":"European projections of West Nile virus transmission under climate change scenarios","volume":"16","author":"Farooq","year":"2023","journal-title":"One Health"},{"key":"10.1016\/j.immuni.2026.05.013_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1089\/vbz.2021.0014","article-title":"Characterizing Areas with Increased Burden of West Nile Virus Disease in California, 2009\u20132018","volume":"21","author":"Danforth","year":"2021","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.immuni.2026.05.013_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14006","article-title":"Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19","volume":"25","author":"Jabr","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.immuni.2026.05.013_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-04797-9","article-title":"Combination anti-HIV antibodies provide sustained virological suppression","volume":"606","author":"Sneller","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.013_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1358\/dot.2021.57.8.3280599","article-title":"Atoltivimab\/maftivimab\/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus","volume":"57","author":"Saxena","year":"2021","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.immuni.2026.05.013_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJMoa2000226","article-title":"Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody","volume":"383","author":"Low","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1473-3099(24)00030-6","article-title":"An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia","volume":"24","author":"Gunale","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.immuni.2026.05.013_bib28","unstructured":"National Library of Medicine, NIH (2018). Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans. https:\/\/clinicaltrials.gov\/study\/NCT03443830."},{"key":"10.1016\/j.immuni.2026.05.013_bib29","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.01178-09","article-title":"Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus","volume":"54","author":"Beigel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.immuni.2026.05.013_bib30","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3201\/eid2511.190537","article-title":"Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease","volume":"25","author":"Gnann","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.immuni.2026.05.013_bib31","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.013_bib33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2026.05.013_bib34","doi-asserted-by":"crossref","first-page":"e20210236","DOI":"10.1084\/jem.20210236","article-title":"Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease","volume":"218","author":"Agudelo","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/iub.1556","article-title":"Molecular basis of antibody-mediated neutralization and protection against flavivirus","volume":"68","author":"Dai","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.immuni.2026.05.013_bib36","doi-asserted-by":"crossref","first-page":"e01049-17","DOI":"10.1128\/JVI.01049-17","article-title":"Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010573","article-title":"A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice","volume":"18","author":"Malonis","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2026.05.013_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2013.10.022","article-title":"Fine mapping of a linear epitope on EDIII of Japanese encephalitis virus using a novel neutralizing monoclonal antibody","volume":"179","author":"Deng","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.immuni.2026.05.013_bib39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.013_bib40","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5694\/mja11.11026","article-title":"Murray Valley encephalitis: a review of clinical features, diagnosis and treatment","volume":"196","author":"Knox","year":"2012","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.immuni.2026.05.013_bib43","first-page":"77","article-title":"Saint Louis Encephalitis Virus, another re-emerging arbovirus: a literature review of worldwide research","volume":"25","author":"Ortiz-Mart\u00ednez","year":"2017","journal-title":"Infez. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/JCM.01932-13","article-title":"Characteristics of antibody responses in West Nile virus-seropositive blood donors","volume":"52","author":"Carson","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.immuni.2026.05.013_bib47","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1084\/jem.20191061","article-title":"Risk of Zika microcephaly correlates with features of maternal antibodies","volume":"216","author":"Robbiani","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001709","article-title":"Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease","volume":"20","author":"Busnadiego","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.immuni.2026.05.013_bib45","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20242039","article-title":"Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design","volume":"222","author":"Groen","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib48","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240365","article-title":"Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies","volume":"221","author":"Fernbach","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451325","article-title":"Highly sensitive reporter cell line for detection of interferon types I\u2013III and their neutralization by antibodies","volume":"54","author":"Groen","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.013_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.013_bib51","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1128\/JVI.03203-15","article-title":"B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts","volume":"90","author":"Priyamvada","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114298","article-title":"Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses","volume":"43","author":"Cervantes Rinc\u00f3n","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.05.013_bib53","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.1073\/pnas.2004325117","article-title":"FcRn, but not Fc\u03b3Rs, drives maternal-fetal transplacental transport of human IgG antibodies","volume":"117","author":"Borghi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.013_bib54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","article-title":"The structural immunology of antibody protection against West Nile virus","volume":"225","author":"Diamond","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2026.05.013_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22773-1","article-title":"A unified route for flavivirus structures uncovers essential pocket factors conserved across pathogenic viruses","volume":"12","author":"Hardy","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.013_bib56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jmedent\/43.2.309","article-title":"Effects of temperature on the transmission of West Nile virus by Culex tarsalis (Diptera: Culicidae)","volume":"43","author":"Reisen","year":"2006","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.immuni.2026.05.013_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-45290-3","article-title":"Contribution of climate change to the spatial expansion of West Nile virus in Europe","volume":"15","author":"Erazo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.013_bib58","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2256424","article-title":"A virus becomes a global concern: research activities on West-Nile virus","volume":"12","author":"Klingelh\u00f6fer","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.immuni.2026.05.013_bib59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.immuni.2026.05.013_bib60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1098\/rspb.1957.0049","article-title":"Virus interference. II. Some properties of interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.immuni.2026.05.013_bib61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/oxfordjournals.bmb.a069760","article-title":"Viral interference and interferon","volume":"15","author":"Isaacs","year":"1959","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.immuni.2026.05.013_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002407","article-title":"A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection","volume":"7","author":"Pinto","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2026.05.013_bib63","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival","volume":"79","author":"Samuel","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib64","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1128\/JVI.00918-08","article-title":"Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection","volume":"82","author":"Daffis","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib65","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ard-2022-222549","article-title":"Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-\u03b1","volume":"81","author":"Mathian","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2026.05.013_bib66","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220258","article-title":"Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination","volume":"220","author":"Sokal","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abp8966","article-title":"Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs","volume":"8","author":"Bastard","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.013_bib68","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.celrep.2018.10.031","article-title":"A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates","volume":"25","author":"Keeffe","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.05.013_bib69","doi-asserted-by":"crossref","first-page":"12400","DOI":"10.1073\/pnas.0603488103","article-title":"West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody","volume":"103","author":"Kaufmann","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.013_bib70","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2010.12.020","article-title":"Antibody-mediated neutralization of flaviviruses: a reductionist view","volume":"411","author":"Dowd","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2026.05.013_bib71","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.chembiol.2022.02.004","article-title":"Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo","volume":"29","author":"Georgiev","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.immuni.2026.05.013_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"Austin","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2026.05.013_bib73","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States","volume":"57","author":"Hayes","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib74","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/v6020606","article-title":"Clinical manifestations and outcomes of West Nile virus infection","volume":"6","author":"Sejvar","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.immuni.2026.05.013_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-91996-9","article-title":"Early warning system of the seasonal West Nile virus infection risk in humans in Northern Greece, 2020\u20132024","volume":"15","author":"Angelou","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2026.05.013_bib76","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jiph.2024.01.008","article-title":"Early warning of potential epidemics: A pilot application of an early warning tool to data from the pulmonary clinic of the university hospital of Thessaly, Greece","volume":"17","author":"Meletis","year":"2024","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.immuni.2026.05.013_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese encephalitis: the virus and vaccines","volume":"10","author":"Yun","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.immuni.2026.05.013_bib78","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/vaccines11040742","article-title":"Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines","volume":"11","author":"Srivastava","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.immuni.2026.05.013_bib79","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/651271","article-title":"Japanese encephalitis: new options for active immunization","volume":"50","author":"Halstead","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.immuni.2026.05.013_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade0958","article-title":"Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein","volume":"8","author":"Bianchini","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.013_bib81","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.013_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1084\/jem.20031550","article-title":"Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies","volume":"199","author":"Meffre","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib83","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.05.013_bib84","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.immuni.2026.05.013_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2026.05.013_bib86","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2026.05.013_bib87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2026.05.013_bib88","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2026.05.013_bib89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.immuni.2026.05.013_bib90","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3181\/00379727-77-18884","article-title":"Isolation from human sera in Egypt of a virus apparently identical to West Nile virus","volume":"77","author":"Melnick","year":"1951","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES2014.19.31.20867","article-title":"West Nile virus lineage 2 isolated from Culex modestus mosquitoes in the Czech Republic, 2013: expansion of the European WNV endemic area to the North?","volume":"19","author":"Rudolf","year":"2014","journal-title":"Euro Surveill."},{"key":"10.1016\/j.immuni.2026.05.013_bib92","unstructured":"Official Gazette of the Republic of Serbia. (2019). Regulation on blood or blood component donors: 6\/2019-132. https:\/\/www.pravno-informacioni-sistem.rs\/SlGlasnikPortal\/eli\/rep\/sgrs\/ministarstva\/pravilnik\/2019\/6\/11."},{"key":"10.1016\/j.immuni.2026.05.013_bib93","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.013_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46321-9","article-title":"Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria","volume":"15","author":"Foss","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.013_bib96","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/2472555218823547","article-title":"TSA-CRAFT: A Free Software for Automatic and Robust Thermal Shift Assay Data Analysis","volume":"24","author":"Lee","year":"2019","journal-title":"SLAS Discov."},{"key":"10.1016\/j.immuni.2026.05.013_bib97","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/nprot.2016.102","article-title":"Sequencing and cloning of antigen-specific antibodies from mouse memory B cells","volume":"11","author":"von Boehmer","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2026.05.013_bib98","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-021-03461-y","article-title":"Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice","volume":"593","author":"De Gasparo","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.013_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2026.05.013_bib100","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.013_bib101","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1073\/pnas.1919269117","article-title":"Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody","volume":"117","author":"Esswein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.013_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000908","article-title":"Few and far between: how HIV may be evading antibody avidity","volume":"6","author":"Klein","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2026.05.013_bib102","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1107\/S0907444909047374","article-title":"Integration, scaling, space-group assignment and post-refinement","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2026.05.013_bib103","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1107\/S2059798323003595","article-title":"The CCP4 suite: integrative software for macromolecular crystallography","volume":"79","author":"Agirre","year":"2023","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.immuni.2026.05.013_bib104","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.immuni.2026.05.013_bib105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-1-60327-058-8_28","article-title":"Automated structure solution with the PHENIX suite","volume":"426","author":"Zwart","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2026.05.013_bib106","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.05.013_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.immuni.2026.05.013_bib108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4939-6740-7_16","article-title":"Bioinformatics Tools and Resources for Analyzing Protein Structures","volume":"1549","author":"Paxman","year":"2017","journal-title":"Methods Mol. Biol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:31:04Z","timestamp":1793107864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761326002244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":108,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1074761326002244"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.013","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of West Nile disease convalescents identifies human monoclonal antibodies protective against West Nile and related orthoflaviviruses","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}